ClinicalTrials.gov
public full text
Public Domain
Single-dose AME Study With [14C]AR882 in Healthy Male Subjects
This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single dose of \[14C\]AR882 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 144 hours following the single dose of AR882 to measure total radioactivity and plasma drug concentrations.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males#909478
- Multiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers#1163320
- Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma#892650
- AVERT-DOSE Statistical Analysis Plan#18848
- 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes#261484
Record · ID 1125944
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive